Syngen Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	275.47	341.93	366.89	246.05	314.8
Cash & Short-Term Investments	275.47	341.93	366.89	246.05	314.8
Cash Growth	-19.44%	-6.80%	49.11%	-21.84%	-25.65%
Accounts Receivable	462.13	422.56	387.8	472.06	388.16
Other Receivables	0.01	0	0	0	0
Receivables	462.14	422.56	387.8	472.06	388.16
Inventory	361.67	345.62	348.99	369.35	291.96
Prepaid Expenses	41.91	44.93	28.77	25.42	23.17
Total Current Assets	1,141	1,155	1,132	1,113	1,018
Property, Plant & Equipment	1,459	1,518	1,526	1,543	1,035
Long-Term Investments	333.08	324.34	331.74	313.75	293.55
Other Intangible Assets	37.87	27.57	24.13	22.96	23.42
Long-Term Deferred Tax Assets	16.89	18.86	17.44	16.21	12.32
Other Long-Term Assets	59.61	38.4	73.21	58.7	28.23
Total Assets	3,048	3,085	3,106	3,071	2,416
Accounts Payable	234.75	255.87	226.47	248.45	236.86
Accrued Expenses	-	78.84	72.8	79.89	64.72
Short-Term Debt	-	-	80	230	-
Current Portion of Long-Term Debt	59.03	59.03	59.03	-	-
Current Portion of Leases	15.17	14.71	13.38	14.85	13.7
Current Income Taxes Payable	33.55	35.18	62.06	76.99	58.39
Current Unearned Revenue	37.16	24.83	20.04	6.73	6.55
Other Current Liabilities	139.93	51.7	50.81	62.56	38.4
Total Current Liabilities	519.58	520.16	584.58	719.47	418.61
Long-Term Debt	4.92	163.95	222.97	182	50
Long-Term Leases	146.08	160.25	163.1	173.93	172.39
Long-Term Deferred Tax Liabilities	4.32	4.17	3.98	3.93	3.16
Total Liabilities	674.89	848.52	974.63	1,079	644.16
Common Stock	271.01	271.01	271.01	271.01	271.01
Additional Paid-In Capital	610.94	618.24	618.2	618.06	612.83
Retained Earnings	1,480	1,344	1,243	1,103	887.88
Comprehensive Income & Other	10.95	2.73	-0.26	-0.07	-0.36
Shareholders' Equity	2,373	2,236	2,132	1,992	1,771
Total Liabilities & Equity	3,048	3,085	3,106	3,071	2,416
Total Debt	225.19	397.93	538.49	600.78	236.08
Net Cash (Debt)	50.27	-56	-171.6	-354.73	78.72
Net Cash Growth	-	-	-	-	-54.53%
Net Cash Per Share	1.85	-2.06	-6.33	-13.07	2.90
Filing Date Shares Outstanding	27.12	27.1	27.1	27.1	27.1
Total Common Shares Outstanding	27.12	27.1	27.1	27.1	27.1
Working Capital	621.61	634.89	547.87	393.41	599.48
Book Value Per Share	87.52	82.51	78.66	73.49	65.36
Tangible Book Value	2,335	2,209	2,107	1,969	1,748
Tangible Book Value Per Share	86.12	81.49	77.76	72.64	64.50
Land	-	251	251	251	-
Buildings	-	729.7	717.09	702.28	532.98
Machinery	-	1,022	871.44	841.51	693.37
Construction In Progress	-	74.67	146.33	114.01	111.97

Source: S&P Global Market Intelligence. Standard template. Financial Sources.